Relay Therapeutics Insider Sold Shares Worth $331,131, According to a Recent SEC Filing
() -- Thomas Catinazzo, Chief Financial Officer, on July 06, 2026, sold 17,717 shares in Relay Therapeutics (RLAY) for $331,131. Following the Form 4 filing with the SEC, Catinazzo has control over a total of 159,744 common shares of the company, with 159,744 shares held directly. SEC Filing: Copyright © 2026. All righ